Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06402_nanopub.RAWY3T61L7nGOTYxVMUMXAv41z6ZiLxGA9D5jBulMtxJA#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB06402 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06402 label "Telavancin [drugbank:DB06402]" assertion.
- drugbank:DB06402 seeAlso vibativ-drug.htm assertion.
- drugbank:DB06402 seeAlso telavancin.html assertion.
- drugbank:DB06402 seeAlso DB06402 assertion.
- drugbank:DB06402 description "Telavancin is a semi-synthetic derivative of vanocymycin that has bactericidal activity against Methicillin-resistant Staphylococcus aureus (MRSA is an important pathogen causing hospital-acquired pneumonia (HAP) worldwide) and other gram-positive bacteria. FDA approved on September 11, 2009." assertion.
- drugbank:DB06402 identifier "drugbank:DB06402" assertion.
- drugbank:DB06402 title "Telavancin" assertion.
- drugbank:DB06402 drugbank_vocabulary:x-cas cas:372151-71-8 assertion.
- drugbank:DB06402 drugbank_vocabulary:drugbank-id "DB06402" assertion.
- drugbank:DB06402 bio2rdf_vocabulary:x-identifiers.org DB06402 assertion.
- drugbank:DB06402 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06402" assertion.
- drugbank:DB06402 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06402 bio2rdf_vocabulary:identifier "DB06402" assertion.
- drugbank:DB06402 drugbank_vocabulary:x-wikipedia wikipedia:Telavancin assertion.
- drugbank:DB06402 drugbank_vocabulary:x-kegg kegg:D06057 assertion.
- drugbank:DB06402 drugbank_vocabulary:x-chebi chebi:71226 assertion.
- drugbank:DB06402 drugbank_vocabulary:x-atc atc:J01XA03 assertion.
- drugbank:DB06402 drugbank_vocabulary:x-ahfs ahfs:8:12.28.16 assertion.
- drugbank:DB06402 drugbank_vocabulary:x-ndc ndc:0469-3575-50 assertion.